TEMEL, T. Et Al. 2017. Hepatitis B Virus Belated Reverse Sero-conversion After Hematopoietic Stem Cell Transplantation or Rituximab Chemotherapy. FLORA INFEKSIYON HASTALIKLARI VE KLINIK MIKROBIYOLOJI DERGISI , vol.22, no.3 , 132-136.

TEMEL, T., OĞUZ DAVUTOĞLU, N., Ozgenel, S. M., ÜSKÜDAR TEKE, H., GÜNDÜZ, E., & ÖZAKYOL, A., (2017). Hepatitis B Virus Belated Reverse Sero-conversion After Hematopoietic Stem Cell Transplantation or Rituximab Chemotherapy. FLORA INFEKSIYON HASTALIKLARI VE KLINIK MIKROBIYOLOJI DERGISI , vol.22, no.3, 132-136.

TEMEL, TUNCER Et Al. "Hepatitis B Virus Belated Reverse Sero-conversion After Hematopoietic Stem Cell Transplantation or Rituximab Chemotherapy," FLORA INFEKSIYON HASTALIKLARI VE KLINIK MIKROBIYOLOJI DERGISI , vol.22, no.3, 132-136, 2017

TEMEL, TUNCER Et Al. "Hepatitis B Virus Belated Reverse Sero-conversion After Hematopoietic Stem Cell Transplantation or Rituximab Chemotherapy." FLORA INFEKSIYON HASTALIKLARI VE KLINIK MIKROBIYOLOJI DERGISI , vol.22, no.3, pp.132-136, 2017

TEMEL, T. Et Al. (2017) . "Hepatitis B Virus Belated Reverse Sero-conversion After Hematopoietic Stem Cell Transplantation or Rituximab Chemotherapy." FLORA INFEKSIYON HASTALIKLARI VE KLINIK MIKROBIYOLOJI DERGISI , vol.22, no.3, pp.132-136.

@article{article, author={TUNCER TEMEL Et Al. }, title={Hepatitis B Virus Belated Reverse Sero-conversion After Hematopoietic Stem Cell Transplantation or Rituximab Chemotherapy}, journal={FLORA INFEKSIYON HASTALIKLARI VE KLINIK MIKROBIYOLOJI DERGISI}, year=2017, pages={132-136} }